Back to Results
First PageMeta Content
Medicine / Clinical research / Biologic / Health / National Institute for Health and Clinical Excellence / Nice / Biosimilar / Biotechnology / Drugs


NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE NICE’s biosimilars position statement NICE’s approach on biosimilars is: a. NICE will consider similar biological medicinal products notified to it by the National
Add to Reading List

Document Date: 2014-12-15 06:52:31

Open Document

File Size: 165,88 KB

Share Result on Facebook

Country

United Kingdom / /

Facility

National Institute / /

IndustryTerm

similar biological medicinal product / NICE technology appraisals / reference products / similar biological medicinal products / technology appraisal / licensed biosimilar products / /

Organization

National Institute / Department of Health / NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE NICE / Health Research Horizon Scanning Centre / /

SocialTag